Horizon Therapeutics PLC (NASDAQ:HZNP)
| 88.03 Delayed Data As of May 24 |  +0.65 / +0.74%Today’s Change | 82.51 Today|||52-Week Range 120.54 | -18.31% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 325.3M | 355.5M | 280.4M | 320.6M | |
| Cost of Goods Sold | 29.8M | 40.5M | 29.3M | 30.0M | ||
| Depreciation And Amortization | 69.2M | 69.0M | 58.9M | 59.1M | ||
| Operating Expenses | Gross Income | 226.3M | 246.0M | 192.2M | 231.5M | |
| General Expenses | 181.3M | 194.3M | 194.0M | 195.4M | ||
| Research And Development | 21.2M | 19.7M | 21.7M | 28.3M | ||
| Total Operating Expenses | 280.3M | 303.8M | 282.2M | 284.6M | ||
| Non-Operating Expenses | Operating Income | 45.0M | 51.7M | -1.8M | 36.1M | |
| Extraordinary Charge | -3.1M | -10.8M | -5.6M | -11.9M | ||
| Interest Expense On Debt | 30.4M | 29.8M | 27.5M | 22.0M | ||
| Other Expenses | 12.8M | 29.6M | 128.0K | -12.2M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 24.3M | 40.7M | -34.8M | -10.0M | |
| Income Taxes | -1.7M | -46.8M | -1.9M | -4.9M | ||
| Net Income | 26.0M | 87.6M | -32.9M | -5.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 167.0M | 168.1M | 172.8M | 185.3M | |
| Shares To Calculate EPS Diluted | 172.5M | 174.2M | 172.8M | 185.3M | ||
| Earnings Per Share | EPS | $0.15 | $0.50 | -$0.19 | -$0.03 | |
| EPS Diluted | $0.15 | $0.50 | -$0.19 | -$0.03 | ||
